← Back to Patent Explorer
US4997950A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel C-terminal gastrin antagonists

Assignee: Individual
•
Filing: 1989-04-20
•
Granted: 1991-03-05
•
Expires: 2009-04-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A series of derivatives of the biologically active C-terminus of gastrin was synthesized to study the structural activity of the molecule and also to determine the smallest and highest affinity inhibitor of gastrin. Earlier work speculated that a peptide resistant to dipeptidase contained in a receptor would be an effective gastrin antagonist. Methods: Five dogs with both chronic gastric fistulae and Heidenhein pouches were used. After an 18 hour fast, gastric juice was collected both from the gastric fistula and pouch over 200 minutes at 10 minute intervals. MMC (Migrating Motor Complex) was monitored by a small balloon in the gastric antrum. Collections were initiated at the beginning of phase I of the MMC and were obtained under 3 conditions: Control, pentagastrin infusion (0.5 μg/Kg/h, i.v.) and pentagastrin+peptide infusion (Indole propionic acid [IPA]- Leu-Asp-Phenethyl amine [PEA], Boc-Trp-Leu-βAla, IPA-Leu-βAla, or Boc-Trp-Leu-Asp-methyl meta Aminobenzoic acid {mABAOMe] at 20 pmol/kg/h for 70 min.). Pentagastrin infusion was started immediately before the next peak of the MMC. Peptides were infused 60 minutes after starting pentagastrin infusion. Results: All four peptides inhibited the stimulated acid secretion causing it to approach the control level. ______________________________________ Inhibition of the stimulated acid secretion (Δ meq/kg) Heidenhein Gastric Fistula Pouch ______________________________________ IPA--Leu--Asp--PEA ↓303 ± 120* ↓18 ± 11* Boc--Trp--Leu-βAla ↓618 ± 168** ↓35 ± 8** IPA--Leu-βAla ↓562 ± 249* ↓34 ± 12* Boc--Trp--Leu--Asp- ↓446 ± 172** ↓40 ± 16** mABAOMe ______________________________________ (*p < 0.05 **p < 0.01, mean ± s.e.) It is concluded that even small di-and tripeptide derivatives of the gastrin C-terminal fragment with varied resistance to hydrolysis can exhibit antagonist activity to pentagastrin stimulated gastric acid secretion.

Inventors

  • 👤 Richard Finbar Murphy
  • 👤 Alistair J. Douglas
  • 👤 Brian Walker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 16:43
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0821; C07K14/00; C07K14/435; C07K14/575; C07K14/595; C07K5/02; C07K5/0202; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06034; C07K5/06043; C07K5/0802; C07K5/0812; C07K5/10; C07K5/1024; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 19 words
A compound having the following formula: ##STR14## where R is biotin-NH, dansyl-NH, and fluorescein-NH, H--, or Nh 2 --.
Claim 2
Dependent Claim 19 words
A compound having the following formula: ##STR14## where R is biotin-NH, dansyl-NH, and fluorescein-NH, H--, or Nh 2 --.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-03-04 1994-09-03 1995-03-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-03-04 1998-09-03 1999-03-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-03-04 2002-09-03 2003-03-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag